Intra-cellular Therapies, Inc.

This study tests an experimental drug called ITI-1284 in adults with generalized anxiety disorder (GAD) who still have symptoms despite current treatments. About 570 participants will receive either the drug or a placebo to see if it reduces anxiety and is safe. The goal is to fi…

This study tests whether a new drug, ITI-1284, can help adults with generalized anxiety disorder (GAD) whose current treatments aren't working well enough. About 705 participants will receive either ITI-1284 or a placebo alongside their usual therapy. The goal is to see if the dr…

This study tests an experimental drug, ITI-1284, to see if it can safely reduce agitation in people with Alzheimer's dementia. About 320 participants will receive either the drug or a placebo, and their agitation levels will be measured using a caregiver questionnaire. The goal i…

This study tests an experimental drug called ITI-1284 to see if it can safely reduce psychosis symptoms like hallucinations and delusions in people with Alzheimer's disease. About 370 participants will receive either the drug or a placebo, and researchers will measure changes in …